It has good biocompatibility and excellent antiserum performance, and can simultaneously deliver programmed cell death ligand 1 (PD-L1) siRNA and doxorubicin (DOX) into MCF-7 cells, which has a significant inhibitory effect on tumor cell proliferation and PD-L1 expression. This evidence concerns the gene CD274 and neoplasm.